nasonex 50 micrograme/doza
organon heist bv - belgia - mometasonum - spray naz.,susp. - 50micrograme/doza - decongestionante si alte medicamente nazale de uz topic corticosteroidiene
nasonex 0,5 mg/g; 50 mcg/dawkę aerozol do nosa, zawiesina
organon polska sp. z o.o. - mometasoni furoas - aerozol do nosa, zawiesina - 0,5 mg/g; 50 mcg/dawkę
nasometin 50 mcg/dawkę odmierzoną aerozol do nosa, zawiesina
sandoz gmbh - mometasoni furoas - aerozol do nosa, zawiesina - 50 mcg/dawkę odmierzoną
nasometin control 50 mcg/dawkę aerozol do nosa, zawiesina
sandoz gmbh - mometasoni furoas monohydricum - aerozol do nosa, zawiesina - 50 mcg/dawkę
nasonex®
organon farmacÊutica ltda. - furoato de mometasona monoidratado - produtos para terapia nasal de acao especifica
nasonex erogazione spray nasale
organon gmbh - mometasoni-17 furoas - erogazione spray nasale - mometasoni-17 furoas 0.5 mg, cellulosum microcristallinum et carmellosum natricum, glycerolum, acidum citricum monohydricum, natrii citras dihydricus, polysorbatum 80, benzalkonii chloridum 0.2 mg, aqua purificata, ad suspensionem pro 1 g corresp., mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140. - rinite, nasenpolypen - synthetika
nasonex dosage spray nasal
organon gmbh - mometasoni-17 furoas - dosage spray nasal - mometasoni-17 furoas 0.5 mg, cellulosum microcristallinum et carmellosum natricum, glycerolum, acidum citricum monohydricum, natrii citras dihydricus, polysorbatum 80, benzalkonii chloridum 0.2 mg, aqua purificata, ad suspensionem pro 1 g corresp., mometasoni-17 furoas 50 µg pro dosi, doses pro vase 140. - rhinite, nasenpolypen - synthetika
nasonex
organon (new zealand) limited - mometasone furoate monohydrate 51.7ug equivalent to 50 mcg mometasone furoate - nasal spray solution - 50 mcg/dose - active: mometasone furoate monohydrate 51.7ug equivalent to 50 mcg mometasone furoate excipient: benzalkonium chloride citric acid monohydrate dispersible cellulose glycerol polysorbate 80 purified water sodium citrate dihydrate - nasonex nasal spray is indicated for the treatment of symptoms associated with seasonal allergic rhinitis and perennial allergic rhinitis and the prophylaxis of seasonal allergic rhinitis inadults, adolescents and children between the ages of 3 and 11 years.
nasonex naspr.sus 0,05% w/w
n.v. organon holland kloosterstraat 6, 5349 ab oss - mometasone furoate monohydrate (micronised) - naspr.sus (ΡΙΝΙΚΟ ΕΚΝΕΦΩΜΑ, ΕΝΑΙΩΡΗΜΑ) - 0,05% w/w - mometasone furoate monohydrate (micronised) 0,5mg - mometasone
nasonex nefúði, dreifa 50 míkróg/skammt
n.v. organon* - mometasonum fúróat - nefúði, dreifa - 50 míkróg/skammt